• Lower Quality of Life Linked to Behavioral Problems in Fragile X Children, Parents Report
  • NORD Webinar Outlines COVID-19 Response on Financial, Policy Fronts
  • Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say
  • Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak
  • Expressive Language Sampling May Aid Research in Fragile X
  • NORD Opens COVID-19 Financial Aid Program for Rare Disease Community
  • Clinical Symptoms and/or Family History of FXS Identify 96% of FXS Cases, Canadian Study Says
  • Antipsychotic Medication Trifluoperazine Shows Promise for Fragile X, Study Finds
  • Urine microRNA Is Potential Biomarker for Fragile X, Early Study Suggests
  • NORD’s Advice on COVID-19: You’re Stronger Than You Think
  • Israeli Clinic for Fragile X, One of World’s Largest, Adapting with COVID-19
  • NORD Partners with ‘Sing Me a Story’ for July 18-20 Living Rare Forum